Table 2.
Participants | 2013 MDA | 2014 MDA | 2014 MDA or DEC | |
---|---|---|---|---|
Antigen‐negative | All n = (%) | 22 (47.8%) | 28 (62.2%) | 27 (62.8%) |
Males n = (%) | 13 (65.0%) | 2 (11.1%) | 11 (73.3%) | |
Females n = (%) | 9 (34.6%) | 16 (59.3%) | 16 (57.1%) | |
Antigen‐positive | All n = (%) | 17 (34.0%) | 25 (59.5%) | 24 (70.6%) |
Males n = (%) | 15 (65.2%) | 9 (47.4%) | 8 (66.7%) | |
Females n = (%) | 2 (7.4%) | 16 (69.6%) | 16 (72.7%) |
DEC, diethylcarbamazine citrate; MDA, mass drug administration of albendazole and DEC.